Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

NASDAQ Extension until March 7

At a hearing held on January 10, 2019, the Company presented its plan to regain and maintain compliance with Nasdaq’s continued listing requirements. Following the March 7, 2019 deadline, the Panel will determine whether a further extension period is warranted in the event the Company has not regained compliance.

Wow, they are given just over 5 weeks to execute their plan. That is barely an extension. Is that even enough time to do another reverse split?